The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Affiliation
Medical Center – University of Freiburg
Country
Germany
Current position
Prof. Dr. Martin J. Hug is chief pharmacist at the Medical Center and Professor at the Institute of Pharmaceutical Sciences – University of Freiburg, Germany. After appointments as assistant professor at the Institute of Physiology in Freiburg, the Department of Cell Biology and Physiology, University of Pittsburgh Medical Center and the Institut of Physiology II, University of Münster Martin Hug worked as head of laboratory at Aventis Pharma In 2013 he joined the staff of the hospital pharmacy in Freiburg. In 2015 he was elected into the Scientific advisory board of the German Federal Chamber of Pharmacists. Martin Hug is an active member of the German Society of Hospital Pharmacists and has been working on several aspects of medication safety.
Education
Prof. Dr. Hug received his training at the University of Freiburg, where he also received a Ph.D. degree in 1992. After years of conducting research studies in physiology and pharmacology he obtained a postdoctoral degree (habilitation) in 2013. In 2018 he was appointed Professor for Clinical Pharmacy at the Institute of Pharmaceutical Sciences – University of Freiburg, Germany.
Research area
Prof. Dr. Hug’s research focuses on the investigation of electrolyte transport across biological membranes. He is also involved in a number of projects dealing with the measurement of serum levels of novel drugs. Recently Prof. Hug has been spent a substantial part of his time with the implementation of the Falsified Medicines Directive in Hospital pharmacies. He’s currently actively involved in the evaluation of electronic patient information leaflets.
Conflict of interest
None